Research and Markets, the largest resource for market research information in world providing essential market research reports, industry research, industry analysis, forecasts, market studies, company profiles and country reports.
Welcome - Register - Login - Help/FAQ - 0 items View Basket
Worlds Largest Market Research Resource - 1516440 Live Reports
Search Research and Markets
  Search
Enter keywords, a title or
a report id number below.





Advanced   
Register for free email updates of market research
Currency
  Select a currency for use throughout the site



Search Results

Your Search for 'PharmaVitae : Roche Global Analysis' returned 17 results - Page 1 of 1

  Sort by   
  Sorted by Rank Top-Bottom

F. Hoffmann-La Roche Ltd: PharmaVitae Profile  
Datamonitor, June 2011, Pages: 94
F. Hoffmann-La Roche Ltd: PharmaVitae Profile Introduction This analysis examines the historical and forecast performance for Roche in the prescription pharmaceutical sector. The profile encompasses


F. Hoffmann-La Roche Ltd.: PharmaVitae Profile  
Datamonitor, July 2010, Pages: 117
F. Hoffmann-La Roche Ltd.: PharmaVitae Profile This analysis examines the historical and forecast performance for Roche in the prescription pharmaceutical sector. The profile encompasses global


Chugai Pharmaceutical Co., Ltd: PharmaVitae Profile  
Datamonitor, Nov 2010, Pages: 104
Chugai Pharmaceutical Co., Ltd: PharmaVitae Profile Introduction This analysis examines the historical and forecast performance for Chugai in the prescription pharmaceutical sector. The profile


Bayer Schering Pharma AG: PharmaVitae Profile  
Datamonitor, June 2010, Pages: 116
Bayer Schering Pharma AG: PharmaVitae Profile Introduction This analysis examines the historical and forecast performance for Bayer Schering in the prescription pharma sector. The profile


Bayer AG: PharmaVitae Profile  
Datamonitor, June 2010
Bayer AG: PharmaVitae Profile This analysis examines the historical and forecast performance for Bayer in the prescription pharmaceutical sector. The profile encompasses global company strategy


Chugai Pharmaceutical Co. Ltd: PharmaVitae Profile  
Datamonitor, Oct 2009, Pages: 113
Chugai Pharmaceutical Co. Ltd: PharmaVitae Profile This analysis examines the historical and forecast performance for Chugai in the prescription pharmaceutical sector. The profile encompasses global


The Neurotechnology Industry 2011 Report  
NeuroInsights, May 2011, Pages: 500+
The Neurotechnology Industry 2011 Report Drugs, Biologics, Stem Cells, Devices and Diagnostics for the Brain and Nervous System: Market Analysis and Strategic Investment Guide of the Global


Big Pharma Mega-Mergers 1995-2014  
Datamonitor, Dec 2009, Pages: 114
company over the period 1995-2014 Chapter 1 Introduction Scope of analysis Methodology Company coverage Data sources Re-creating analysis from this report using PharmaVitae Explorer queries Further


Genzyme Corporation  
Datamonitor, May 2011, Pages: 95
Genzyme Corporation This analysis examines the historical and forecast performance for Genzyme in the prescription pharmaceutical sector. The profile encompasses global company strategy, portfolio


Pharmaceutical Licensing Overview  
Datamonitor, March 2010, Pages: 114
Company classifications Explanation of launch/core/expiry analysis 3. Licensing Trends Overview Key findings Big Pharma trends Big Pharma's reliance on externally sourced products drives sales growth


Genentech Inc.: PharmaVitae Profile  
Datamonitor, March 2009, Pages: 148
Genentech Inc.: PharmaVitae Profile This analysis examines the historical and forecast performance for Genentech in the Rx pharmaceutical sector. The profile encompasses global company strategy


The Central Nervous Systems Market 2010 Report  
NeuroInsights, May 2010
The Central Nervous Systems Market 2010 Report Drugs, Biologics, Stem Cells, Devices and Diagnostics for the Brain and Nervous System: Market Analysis and Strategic Investment Guide of the Global


Chronic Kidney Disease (Chronic Renal Failure) - Pipeline Review, Q1 2011  
Global Markets Direct, Feb 2011, Pages: 100
Chronic Kidney Disease (Chronic Renal Failure) - Pipeline Review, Q1 2011 Chronic Kidney Disease (Chronic Renal Failure) - Pipeline Review, Q1 2011 Summary Global Markets Direct’s, 'Chronic Kidney


Chronic Kidney Disease (Chronic Renal Failure) - Pipeline Review, H2 2011  
Global Markets Direct, Sep 2011, Pages: 87
. Hoffmann-La Roche Ltd. Abbott Laboratories Amgen Inc. Eli Lilly and Company Quark Pharmaceuticals, Inc. Merck & Co., Inc. MD Scientific, LLC Astellas Pharma Inc. Mitsubishi Tanabe


GlaxoSmithKline: Pipeline, Products, Performance and Potential  
Espicom Business Intelligence Ltd, Oct 2009, Pages: 290
Subsidiaries and joint ventures - Adherex Technologies Inc - Adolor Corporation - Aeras Global TB Vaccine Foundation - Antigenics Inc - Aphton Corporation - Asahi Chemical Industry Co - Astellas Pharma - AVANT


Alzheimer's Disease - Pipeline Review, H1 2012  
Global Markets Direct, Feb 2012, Pages: 253
Alzheimer's Disease - Pipeline Review, H1 2012 Alzheimer's Disease – Pipeline Review, H1 2012 Summary Global Markets Direct’s, 'Alzheimer's Disease - Pipeline Review, H1 2012', provides an overview


Monoclonal Antibodies Report: 2008 Update  
Datamonitor, June 2008, Pages: 363
of pipeline dynamics. Scope - Comprehensive financial strategic analysis of the mAb market out to 2013 - Global sales forecasts to 2013 for marketed and Phase III mAb products - Analysis of market


Results:  First -   Prev -   1 -   Next -   Last


For enquiries please call us on:
  +353-1-415-1241 (GMT Office Hours)
  1-917-300-0470 (EST Office Hours)

   All rights reserved. © Copyright 2012 Research and Markets
   Terms and conditions Privacy Policy Publishers Employment Opportunities Site Map Link to us Webmaster Affiliate Network


Research and Markets RSS Feeds